Dotplot - About the company
Dotplot is an unfunded company based in London (United Kingdom), founded in 2022. It operates as a Developer of a device and app for breast tissue monitoring. Dotplot has not raised any funding yet. The company has 64 active competitors, including 19 funded and 7 that have exited. Its top competitors include companies like Delphinus Medical Technologies, Wixsite and QT Imaging.
Company Details
Developer of a device and app for breast tissue monitoring. It offers a handheld device that identifies changes in breast tissue density. Paired with an application, it guides users through regular self-checks. The system alerts users to abnormal changes detected over time. It aims to provide customized guidance and objective monitoring of breast health.
Key Metrics
Founded Year
2022
Location
London, United Kingdom
Stage
Unfunded
Ranked
69th among 81 competitors
Employee Count
2 as on Jul 01, 2024
Similar Companies
Sign up to download Dotplot's company profile
Dotplot's funding and investors
Dotplot has not raised any funding rounds yet.
Dotplot's founders and board of directors
Founder? Claim ProfileDotplot's employee count trend
Dotplot has 2 employees as of Jul 24. Here is Dotplot's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Dotplot's Competitors and alternates
Top competitors of Dotplot include Delphinus Medical Technologies, Wixsite and QT Imaging. Here is the list of Top 10 competitors of Dotplot, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Delphinus Medical Technologies 2010, Plymouth (United States), Series D | Platform for breast ultrasound imaging | $137M | 62/100 | |
2nd | Provider of tools enabling users to create and manage websites | - | 62/100 | ||
3rd | QT Imaging 2012, Novato (United States), Public | Developer of a non-invasive ultrasound imaging device for detecting breast cancer | $28.8M | 58/100 | |
4th | iSono Health 2014, San Francisco (United States), Seed | Provider of AI-based 3D wearable device for early breast cancer detection | $1.96M | 57/100 | |
5th | CairnSurgical 2015, Lebanon (United States), Series A | Developer of 3D printed surgical guides for breast cancer treatment | $7.79M | 53/100 | |
6th | UE LifeSciences 2009, Philadelphia (United States), Series A | Provider of a non-invasive breast cancer scanning device | $4.76M | 49/100 | |
7th | Koning 2002, United States, Funding Raised | Innovating breast imaging with advanced 3D CT technology | - | 49/100 | |
8th | Micrima 2005, Bristol (United Kingdom), Series A | Provider of non-invasive and a non-ionizing radio wave technology for detecting breast cancer. | $24.4M | 48/100 | |
9th | Developer of 4D imaging sensors for cancer detection and other devices | $296M | 47/100 | ||
10th | iSCANBREAST 2023, Hyderabad (India), Unfunded | Manufacturer of a device designed for women's breast self-examination | - | - | 46/100 |
69th | Dotplot 2022, London (United Kingdom), Unfunded | Developer of a device and app for breast tissue monitoring | - | - | 16/100 |
Looking for more details on Dotplot's competitors? Click here to see the top ones
Dotplot's Investments and acquisitions
Dotplot has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Dotplot
Explore our recently published companies
- Fahrschule-Bernhart - Germany based, Unfunded company
- Hautarzt-Berlin-Residenzstrasse - Germany based, Unfunded company
- Loreleytal - Germany based, 1997 founded, Unfunded company
- Camping-Oberstdorf - Germany based, Unfunded company
- Express-Driver - Germany based, Unfunded company
- Da-Pack - Germany based, Unfunded company
